{"nct_id":"NCT05064059","title":"A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2021-11-10","start_date_type":"ACTUAL","primary_completion_date":"2024-08-15","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}